BACKGROUND: Idiopathic dilated cardiomyopathy is a frequent cause of heart failure, a major concern of public health. Although idiopathic dilated cardiomyopathy may be familial, most cases are sporadic and the disease is considered to be multifactorial, for which genetic factors may account for a significant part. METHODS AND RESULTS: We hypothesized that genetic abnormalities of the endothelin pathway may be involved in idiopathic dilated cardiomyopathy pathophysiology and therefore examined the possible association between idiopathic dilated cardiomyopathy and polymorphisms in genes encoding endothelin 1, endothelin type A and type B receptors, in a case-control study (433 patients and 400 age- and sex-matched control subjects). Analysis of the Exon 8 C/T polymorphism in the endothelin receptor type A gene indicated that individuals who are homozygote for the T allele were at significantly increased risk for the disease (odds ratio: 1.9; 95% confidence interval: 1.2 to 3. 01;P<0.006). Analysis of the other polymorphisms indicated that no significant difference was observed in genotype or allele frequencies between cases and controls. CONCLUSIONS: The variant in the Exon 8 of the endothelin receptor type A gene appears as a genetic risk factor for idiopathic forms of heart failure. These results provide a new approach to the pathophysiology of idiopathic dilated cardiomyopathy. Copyright 1999 The European Society of Cardiology.
BACKGROUND:Idiopathic dilated cardiomyopathy is a frequent cause of heart failure, a major concern of public health. Although idiopathic dilated cardiomyopathy may be familial, most cases are sporadic and the disease is considered to be multifactorial, for which genetic factors may account for a significant part. METHODS AND RESULTS: We hypothesized that genetic abnormalities of the endothelin pathway may be involved in idiopathic dilated cardiomyopathy pathophysiology and therefore examined the possible association between idiopathic dilated cardiomyopathy and polymorphisms in genes encoding endothelin 1, endothelin type A and type B receptors, in a case-control study (433 patients and 400 age- and sex-matched control subjects). Analysis of the Exon 8 C/T polymorphism in the endothelin receptor type A gene indicated that individuals who are homozygote for the T allele were at significantly increased risk for the disease (odds ratio: 1.9; 95% confidence interval: 1.2 to 3. 01;P<0.006). Analysis of the other polymorphisms indicated that no significant difference was observed in genotype or allele frequencies between cases and controls. CONCLUSIONS: The variant in the Exon 8 of the endothelin receptor type A gene appears as a genetic risk factor for idiopathic forms of heart failure. These results provide a new approach to the pathophysiology of idiopathic dilated cardiomyopathy. Copyright 1999 The European Society of Cardiology.
Authors: Rebecca Darrah; Edward McKone; Clare O'Connor; Christine Rodgers; Alan Genatossio; Sharon McNamara; Ronald Gibson; J Stuart Elborn; Madeleine Ennis; Charles G Gallagher; Noor Kalsheker; Moira Aitken; Dawn Wiese; John Dunn; Paul Smith; Rhonda Pace; Douglas Londono; Katrina A B Goddard; Michael R Knowles; Mitchell L Drumm Journal: Physiol Genomics Date: 2009-12-22 Impact factor: 3.107
Authors: Eric Villard; Claire Perret; Françoise Gary; Carole Proust; Gilles Dilanian; Christian Hengstenberg; Volker Ruppert; Eloisa Arbustini; Thomas Wichter; Marine Germain; Olivier Dubourg; Luigi Tavazzi; Marie-Claude Aumont; Pascal DeGroote; Laurent Fauchier; Jean-Noël Trochu; Pierre Gibelin; Jean-François Aupetit; Klaus Stark; Jeanette Erdmann; Roland Hetzer; Angharad M Roberts; Paul J R Barton; Vera Regitz-Zagrosek; Uzma Aslam; Laëtitia Duboscq-Bidot; Matthias Meyborg; Bernhard Maisch; Hugo Madeira; Anders Waldenström; Enrique Galve; John G Cleland; Richard Dorent; Gerard Roizes; Tanja Zeller; Stefan Blankenberg; Alison H Goodall; Stuart Cook; David A Tregouet; Laurence Tiret; Richard Isnard; Michel Komajda; Philippe Charron; François Cambien Journal: Eur Heart J Date: 2011-04-01 Impact factor: 29.983
Authors: Donna K Arnett; Richard B Devereux; Dabeeru C Rao; Na Li; Weihong Tang; Rachel Kraemer; Steven A Claas; Joanlise M Leon; Ulrich Broeckel Journal: J Hypertens Date: 2009-08 Impact factor: 4.844
Authors: Matthew R G Taylor; Dobromir Slavov; Kurt Humphrey; Lan Zhao; Jennifer Cockroft; Xiao Zhu; Philip Lavori; Michael R Bristow; Luisa Mestroni; Laura C Lazzeroni Journal: Pharmacogenet Genomics Date: 2009-01 Impact factor: 2.089
Authors: Klaus Stark; Ulrike B Esslinger; Wibke Reinhard; George Petrov; Thomas Winkler; Michel Komajda; Richard Isnard; Philippe Charron; Eric Villard; François Cambien; Laurence Tiret; Marie-Claude Aumont; Olivier Dubourg; Jean-Noël Trochu; Laurent Fauchier; Pascal Degroote; Anette Richter; Bernhard Maisch; Thomas Wichter; Christa Zollbrecht; Martina Grassl; Heribert Schunkert; Patrick Linsel-Nitschke; Jeanette Erdmann; Jens Baumert; Thomas Illig; Norman Klopp; H-Erich Wichmann; Christa Meisinger; Wolfgang Koenig; Peter Lichtner; Thomas Meitinger; Arne Schillert; Inke R König; Roland Hetzer; Iris M Heid; Vera Regitz-Zagrosek; Christian Hengstenberg Journal: PLoS Genet Date: 2010-10-21 Impact factor: 5.917